剖宫产产后出血诊疗进展

Research progress on treatment of postpartum hemorrhage after cesarean section

剖宫产产后出血(PPH)是临床上产科最常见的并发症之一,同时也是世界范围内的孕产妇怀孕期间死亡的首要因素。宫缩乏力、产道损伤、胎盘异常、凝血功能障碍是剖宫产产后出血的主要原因。剖宫产期间的平均失血量明显高于阴道分娩。目前,如催产素、卡前列素氨丁三醇、米索前列醇等常用作产后出血的止血药物。近年来随着三孩政策的放开,剖宫产率及产后出血风险明显增加。此文对近年来关于剖宫产产后出血诊治方面的文献和进展进行了复习,并对相关文献进行了总结,以期为临床提供一定参考价值。

Postpartum hemorrhage after cesarean section(PPH)is one of the most common complications in clinical obstetrics,but also the leading cause of maternal death during pregnancy worldwide.Uterine weakness,birth canal injury,placenta abnormality,coagulation dysfunction are the main causes of hemorrhage after cesarean section.The average blood loss during cesarean delivery is significantly higher than that during vaginal delivery.At present,such as oxytocin,carprost tritol,misoprostol and other commonly used hemostatic drugs with postpartum bleeding.In recent years,with the development of the three-child policy,cesarean section rate and postpartum bleeding risk increased significantly.This paper reviews the literature and progress on the diagnosis and treatment of postpartum hemorrhage after cesarean section in recent years,and summarizes the relevant literature,to provide certain reference value for clinical practice.